350 related articles for article (PubMed ID: 34492225)
1. Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection.
Luchetti G; Roncaioli JL; Chavez RA; Schubert AF; Kofoed EM; Reja R; Cheung TK; Liang Y; Webster JD; Lehoux I; Skippington E; Reeder J; Haley B; Tan MW; Rose CM; Newton K; Kayagaki N; Vance RE; Dixit VM
Cell Host Microbe; 2021 Oct; 29(10):1521-1530.e10. PubMed ID: 34492225
[TBL] [Abstract][Full Text] [Related]
2. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages.
Suzuki S; Mimuro H; Kim M; Ogawa M; Ashida H; Toyotome T; Franchi L; Suzuki M; Sanada T; Suzuki T; Tsutsui H; Núñez G; Sasakawa C
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4254-63. PubMed ID: 25246571
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions.
Hansen JM; de Jong MF; Wu Q; Zhang LS; Heisler DB; Alto LT; Alto NM
Cell; 2021 Jun; 184(12):3178-3191.e18. PubMed ID: 34022140
[TBL] [Abstract][Full Text] [Related]
4. Insights into the GSDMB-mediated cellular lysis and its targeting by IpaH7.8.
Yin H; Zheng J; He Q; Zhang X; Li X; Ma Y; Liang X; Gao J; Kocsis BL; Li Z; Liu X; Alto NM; Li L; Zhang H
Nat Commun; 2023 Jan; 14(1):61. PubMed ID: 36599845
[TBL] [Abstract][Full Text] [Related]
5. Structural mechanisms for regulation of GSDMB pore-forming activity.
Zhong X; Zeng H; Zhou Z; Su Y; Cheng H; Hou Y; She Y; Feng N; Wang J; Shao F; Ding J
Nature; 2023 Apr; 616(7957):598-605. PubMed ID: 36991125
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for GSDMB pore formation and its targeting by IpaH7.8.
Wang C; Shivcharan S; Tian T; Wright S; Ma D; Chang J; Li K; Song K; Xu C; Rathinam VA; Ruan J
Nature; 2023 Apr; 616(7957):590-597. PubMed ID: 36991122
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence.
Li P; Jiang W; Yu Q; Liu W; Zhou P; Li J; Xu J; Xu B; Wang F; Shao F
Nature; 2017 Nov; 551(7680):378-383. PubMed ID: 29144452
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitinated gasdermin D mediates arsenic-induced pyroptosis and hepatic insulin resistance in rat liver.
Zhu Y; Zhang J; Yao X; Qiu T; Jiang L; Wang N; Shi Y; Wu C; Yuan W; Yang G; Liu X; Bai J; Men L; Sun X
Food Chem Toxicol; 2022 Feb; 160():112771. PubMed ID: 34920032
[TBL] [Abstract][Full Text] [Related]
9. Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11.
Li Z; Liu W; Fu J; Cheng S; Xu Y; Wang Z; Liu X; Shi X; Liu Y; Qi X; Liu X; Ding J; Shao F
Nature; 2021 Nov; 599(7884):290-295. PubMed ID: 34671164
[TBL] [Abstract][Full Text] [Related]
10. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells.
Ashida H; Nakano H; Sasakawa C
PLoS Pathog; 2013; 9(6):e1003409. PubMed ID: 23754945
[TBL] [Abstract][Full Text] [Related]
11. Gasdermin D is involved in switching from apoptosis to pyroptosis in TLR4-mediated renal tubular epithelial cells injury in diabetic kidney disease.
Yuan S; Wang Y; Li Z; Chen X; Song P; Chen A; Qu Z; Wen S; Liu H; Zhu X
Arch Biochem Biophys; 2022 Sep; 727():109347. PubMed ID: 35809639
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis.
Shi Y; Yang Y; Xu W; Shi D; Xu W; Fu X; Lv Q; Xia J; Shi F
Cell Death Dis; 2022 Feb; 13(2):106. PubMed ID: 35115505
[TBL] [Abstract][Full Text] [Related]
13. Identification of interactions among host and bacterial proteins and evaluation of their role early during Shigella flexneri infection.
Miller KA; Garza-Mayers AC; Leung Y; Goldberg MB
Microbiology (Reading); 2018 Apr; 164(4):540-550. PubMed ID: 29488864
[TBL] [Abstract][Full Text] [Related]
14. GBPs Inhibit Motility of Shigella flexneri but Are Targeted for Degradation by the Bacterial Ubiquitin Ligase IpaH9.8.
Wandel MP; Pathe C; Werner EI; Ellison CJ; Boyle KB; von der Malsburg A; Rohde J; Randow F
Cell Host Microbe; 2017 Oct; 22(4):507-518.e5. PubMed ID: 29024643
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Lytic and Non-Lytic Functions of Gasdermin Pores.
Rühl S; Broz P
J Mol Biol; 2022 Feb; 434(4):167246. PubMed ID: 34537232
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri.
Fritah S; Lhocine N; Golebiowski F; Mounier J; Andrieux A; Jouvion G; Hay RT; Sansonetti P; Dejean A
EMBO Rep; 2014 Sep; 15(9):965-72. PubMed ID: 25097252
[TBL] [Abstract][Full Text] [Related]
17. Shigella hijacks the glomulin-cIAPs-inflammasome axis to promote inflammation.
Suzuki S; Suzuki T; Mimuro H; Mizushima T; Sasakawa C
EMBO Rep; 2018 Jan; 19(1):89-101. PubMed ID: 29191979
[TBL] [Abstract][Full Text] [Related]
18. Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes.
Sandstrom A; Mitchell PS; Goers L; Mu EW; Lesser CF; Vance RE
Science; 2019 Apr; 364(6435):. PubMed ID: 30872533
[TBL] [Abstract][Full Text] [Related]
19. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
[TBL] [Abstract][Full Text] [Related]
20. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.
Kobayashi T; Ogawa M; Sanada T; Mimuro H; Kim M; Ashida H; Akakura R; Yoshida M; Kawalec M; Reichhart JM; Mizushima T; Sasakawa C
Cell Host Microbe; 2013 May; 13(5):570-583. PubMed ID: 23684308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
